Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Psychosis Associated with Alzheimer's Dementia
NCT01438060Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Aug 2000
- Primary completion
- Jul 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of aripiprazole in Alzheimer's disease psychosis (ADP), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Aug 2000; status: completed.
02
Drugs
aripiprazole
03
Conditions
Alzheimer's disease psychosis (ADP)
Beyond the preview
Go deeper on NCT01438060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438060.